0001209191-18-023291.txt : 20180403
0001209191-18-023291.hdr.sgml : 20180403
20180403183939
ACCESSION NUMBER: 0001209191-18-023291
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180402
FILED AS OF DATE: 20180403
DATE AS OF CHANGE: 20180403
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: NIEMANN BRADLEY V.
CENTRAL INDEX KEY: 0001669839
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19961
FILM NUMBER: 18735170
MAIL ADDRESS:
STREET 1: 3451 PLANO PARKWAY
CITY: LEWISVILLE
STATE: TX
ZIP: 75056
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ORTHOFIX INTERNATIONAL N V
CENTRAL INDEX KEY: 0000884624
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 7 ABRAHAM DE VEERSTRAAT
STREET 2: CURACAO
CITY: NETHERLANDS ANTILLES
STATE: P8
ZIP: 00000
BUSINESS PHONE: 214-937-2000
MAIL ADDRESS:
STREET 1: 3451 PLANO PARKWAY
CITY: LEWISVILLE
STATE: TX
ZIP: 75056
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-04-02
0
0000884624
ORTHOFIX INTERNATIONAL N V
OFIX
0001669839
NIEMANN BRADLEY V.
3451 PLANO PKWY
LEWISVILLE
TX
75056
0
1
0
0
President Biostim
Common Stock
2018-04-02
4
A
0
2528
0.00
A
21296
D
Stock Option (right to buy)
56.87
2018-04-02
4
A
0
8973
0.00
A
2028-04-02
Common Stock
8973
8973
D
Performance Share Units
0.00
2018-04-02
4
A
0
5055
0.00
A
2021-04-02
Common Stock
5055
5055
D
Represents time-based vesting restricted stock that vests in 25% increments on the first, second, third and fourth anniversaries of the grant date, April 2, 2018.
These stock options vest in 25% increments on the first, second, third and fourth anniversaries of the grant date, April 2, 2018.
Represents market-based vesting performance stock units ("PSUs") that will settle as common stock on a one-for-one basis. The performance period of the grant is defined as April 2, 2018 to April 2, 2021. The PSUs will vest based on the percentile rank of the Company's total shareholder return ("TSR") over the performance period in relation to the TSR of the specified index companies. The index companies are based upon the companies included within the S&P Healthcare Select Sector index as of April 2, 2018, the grant date. In the event that the Company's TSR ranks at the 75th percentile or greater for the performance period, 200% of the PSUs will vest. In the event that the Company's TSR ranks between the 50th percentile and the 75th percentile, 100-200% of the PSUs will vest and 50-100% of the PSUs will vest if the Company's TSR ranks between the 25th percentile and 50th percentile. No PSUs will vest if the Company ranks below the 25th percentile.
/s/ Kimberley A. Elting, Chief Legal and Administrative Officer, by power of attorney
2018-04-03